168 related articles for article (PubMed ID: 34000484)
1. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Arya GC; Kaur K; Jaitak V
Eur J Med Chem; 2021 Oct; 221():113511. PubMed ID: 34000484
[TBL] [Abstract][Full Text] [Related]
2. A review of synthetic strategy, SAR, docking, simulation studies, and mechanism of action of isoxazole derivatives as anticancer agents.
Arya GC; Khalid M; Mehla S; Jakhmola V
J Biomol Struct Dyn; 2024 Jun; 42(9):4909-4935. PubMed ID: 37315986
[TBL] [Abstract][Full Text] [Related]
3. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.
Kaur K; Jaitak V
Anticancer Agents Med Chem; 2019; 19(8):962-983. PubMed ID: 30864529
[TBL] [Abstract][Full Text] [Related]
4. Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies.
Sahil ; Kaur K; Jaitak V
Curr Med Chem; 2022 Aug; 29(29):4958-5009. PubMed ID: 35306982
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent.
Mokale SN; Sakle NS; Bhavale SA; Lokwani DK; Shelke VR
Anticancer Agents Med Chem; 2018; 18(7):1009-1015. PubMed ID: 29189180
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.
Burra S; Voora V; Rao CP; Vijay Kumar P; Kancha RK; David Krupadanam GL
Bioorg Med Chem Lett; 2017 Sep; 27(18):4314-4318. PubMed ID: 28838692
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Screening of Pro-apoptotic and Angio-inhibitory Activity of Novel Benzisoxazole Derivatives both In Vitro and In Vivo.
Byrappa S; Rachaiah K; Kotian SY; Balaraju Y; Prabhuswamimath SC; Rai KML; Salimath BP
Anticancer Agents Med Chem; 2019; 19(6):827-839. PubMed ID: 30648522
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.
Çalışkan B; Sinoplu E; İbiş K; Akhan Güzelcan E; Çetin Atalay R; Banoglu E
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1352-1361. PubMed ID: 30251900
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents.
Naresh Kumar R; Jitender Dev G; Ravikumar N; Krishna Swaroop D; Debanjan B; Bharath G; Narsaiah B; Nishant Jain S; Gangagni Rao A
Bioorg Med Chem Lett; 2016 Jun; 26(12):2927-2930. PubMed ID: 27130357
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
[TBL] [Abstract][Full Text] [Related]
12. Isoxazole-Derived Aroylhydrazones and Their Dinuclear Copper(II) Complexes Show Antiproliferative Activity on Breast Cancer Cells with a Potentially Alternative Mechanism Of Action.
Rada JP; Forté J; Gontard G; Corcé V; Salmain M; Rey NA
Chembiochem; 2020 Sep; 21(17):2474-2486. PubMed ID: 32282111
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell.
Reddy ST; Mendonza JJ; Makani VKK; Bhadra MP; Uppuluri VM
Bioorg Chem; 2020 Dec; 105():104374. PubMed ID: 33130349
[TBL] [Abstract][Full Text] [Related]
14. Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review.
Sidhu JS; Singla R; Mayank ; Jaitak V
Anticancer Agents Med Chem; 2015; 16(2):160-73. PubMed ID: 25991424
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
Im D; Jung K; Yang S; Aman W; Hah JM
Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
[TBL] [Abstract][Full Text] [Related]
16. Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach.
Devi N; Kaur K; Biharee A; Jaitak V
Anticancer Agents Med Chem; 2021; 21(14):1802-1824. PubMed ID: 33397272
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents.
Pedada SR; Yarla NS; Tambade PJ; Dhananjaya BL; Bishayee A; Arunasree KM; Philip GH; Dharmapuri G; Aliev G; Putta S; Rangaiah G
Eur J Med Chem; 2016 Apr; 112():289-297. PubMed ID: 26907155
[TBL] [Abstract][Full Text] [Related]
18. Potential anticancer agents. I. Synthesis of isoxazole moiety containing quinazoline derivatives and preliminarily in vitro anticancer activity.
Yong JP; Lu CZ; Wu X
Anticancer Agents Med Chem; 2015; 15(1):131-6. PubMed ID: 25142319
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of (Z)-(arylamino)-pyrazolyl/isoxazolyl-2-propenones as tubulin targeting anticancer agents and apoptotic inducers.
Kamal A; Reddy VS; Shaik AB; Kumar GB; Vishnuvardhan MV; Polepalli S; Jain N
Org Biomol Chem; 2015 Mar; 13(11):3416-31. PubMed ID: 25661328
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel isoxazole-piperazine hybrids as potential anti-cancer agents with inhibitory effect on liver cancer stem cells.
İbiş K; Nalbat E; Çalışkan B; Kahraman DC; Cetin-Atalay R; Banoglu E
Eur J Med Chem; 2021 Oct; 221():113489. PubMed ID: 33951549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]